Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹68 Cr₹109 Cr₹61 Cr₹9.13 Cr₹11 Cr

What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH is ₹68 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹68 Cr
Mar2024₹109 Cr
Mar2023₹61 Cr
Mar2022₹9.13 Cr
Mar2021₹11 Cr

How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹68 Cr
-37.42
Mar2024 ₹109 Cr
78.73
Mar2023 ₹61 Cr
567.74
Mar2022 ₹9.13 Cr
-20.30
Mar2021 ₹11 Cr -

Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,596.4 Cr -2.7% -3.8% 12.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-2.7%

-3.8%

12.8%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses